<ul>
	<li>Risk of hypotension, bradycardia, and cardiac failure: Reduce or discontinue use</li>
	<li>Risk of exacerbating reactive airway disease</li>
	<li>Diabetes mellitus: Increases the effect of hypoglycemic agents and masks hypoglycemic tachycardia</li>
	<li>Risk of unopposed alpha-agonism and severe hypertension in untreated pheochromocytoma</li>
	<li>Risk of myocardial ischemia when abruptly discontinued in patients with coronary artery disease</li>
</ul>